» Articles » PMID: 27928615

Clinical Effect of Hyperbaric Oxygen Therapy in the Treatment of Femoral Head Necrosis : A systematic Review and Meta-analysis

Overview
Journal Orthopade
Specialty Orthopedics
Date 2016 Dec 9
PMID 27928615
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although many clinical studies have shown that hyperbaric oxygen (HBO) therapy in the treatment of femoral head necrosis can significantly improve clinical symptoms and patients' quality of life, this conclusion has not been systematically evaluated. Therefore, a meta-analysis was performed to systematically evaluate the clinical effect of HBO therapy in the treatment of femoral head necrosis.

Methods: PubMed, Embase, and Web of Science databases, as well as the reference lists of relevant studies published before August 2016 were systematically searched using terms related to HBO and femoral head necrosis. Fixed or random effects models were used to estimate the pooled risk ratio (RR) with 95% confidence intervals (CI). Several subgroup analyses, sensitivity analyses, and publication bias tests were carried out to explore potential study heterogeneity and bias.

Results: Nine studies involving 305 controls and 318 HBO cases were included. The clinical effect in the HBO therapy group was 4.95-times higher than in the control group (odds ratio, OR = 4.95, 95% CI [3.24,7.55], P < 0.00001) and the difference was statistically significant. According to the principle of subgroup analysis, the population was divided into Asian and non-Asian subpopulations. Subgroup analyses showed that the clinical effect in the HBO therapy group was 4.77-times higher than that of the control group of the Asian subpopulation (OR = 4.77, 95% CI [3.06,7.44], P < 0.00001) and 7.07-times than that of the control group of the non-Asian subpopulation (OR = 7.07, 95% CI [1.77,28.27], P < 0.00001).

Conclusion: The results of this study showed that HBO therapy can significantly improve the clinical treatment effect in patients with femoral head necrosis, and that this treatment approach is worthy of clinical application.

Citing Articles

The use of hyperbaric oxygen for avascular necrosis of the femoral head and femoral condyle: a single centre's experience over 30 years.

Currie J, Gawthrope I, Banham N Diving Hyperb Med. 2024; 54(2):92-96.

PMID: 38870950 PMC: 11444917. DOI: 10.28920/dhm54.2.92-96.


Microrna-206 induces hypoxic necrosis of femoral head by inhibiting VEGF/PI3K/AKT signaling pathway.

Wu X, Tao Z, Cheng W Front Genet. 2023; 14:1118831.

PMID: 36911416 PMC: 9992790. DOI: 10.3389/fgene.2023.1118831.


The Role of Conservative Management in the Avascular Necrosis of the Femoral Head: A Review of Systematic Reviews.

Sai Krishna M, Kar S, Kumar R, Singh H, Mittal R, Digge V Indian J Orthop. 2023; 57(3):410-420.

PMID: 36777071 PMC: 9897604. DOI: 10.1007/s43465-023-00818-5.


Osteonecrosis of the Femoral Head: Update Article.

Miyahara H, Ranzoni L, Ejnisman L, Vicente J, Croci A, Gurgel H Rev Bras Ortop (Sao Paulo). 2022; 57(3):351-359.

PMID: 35785123 PMC: 9246540. DOI: 10.1055/s-0041-1736308.


Treatment options for secondary osteonecrosis of the knee.

Zmerly H, Moscato M, Akkawi I, Galletti R, Di Gregori V Orthop Rev (Pavia). 2022; 14(3):33639.

PMID: 35775038 PMC: 9239350. DOI: 10.52965/001c.33639.


References
1.
Rackwitz L, Eden L, Reppenhagen S, Reichert J, Jakob F, Walles H . Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther. 2012; 3(1):7. PMC: 3340551. DOI: 10.1186/scrt98. View

2.
Kang J, Park S, Song J, Jung Y, Cho M, Rhyu K . Prevalence of osteonecrosis of the femoral head: a nationwide epidemiologic analysis in Korea. J Arthroplasty. 2009; 24(8):1178-83. DOI: 10.1016/j.arth.2009.05.022. View

3.
Lee J, Yu C, Yang J, Baek H, Lee K, Koo T . Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J. 2012; 12(3):239-48. DOI: 10.1016/j.spinee.2012.01.013. View

4.
Johnson A, Mont M, Tsao A, Jones L . Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample. Clin Orthop Relat Res. 2013; 472(2):617-23. PMC: 3890194. DOI: 10.1007/s11999-013-3220-3. View

5.
Bennett M . Hyperbaric oxygen therapy improved both pain scores and range of motion in patients with early idiopathic femoral head necrosis (Ficat stage II). Diving Hyperb Med. 2011; 41(2):105. View